Marisa Meyer, DO, FAAP is a Pediatric Critical Care Medicine physician with 12 years' experience, specializing in Critical Care Transport Medicine and Extracorporeal Membrane Oxygenation. She serves as Medical Director, Pediatric Critical Care Transport Program, and Associate Director, Critical Care ECMO, at Nemours Children's Hospital, Delaware Valley. In addition, she is a Clinical Assistant Professor of Pediatrics and Assistant Research Scientist at the Sidney Kimmel Medical College at Thomas Jefferson University.

Dr. Meyer received her bachelor's degree in biology from The College of New Jersey and her medical degree from Rowan University School of Osteopathic Medicine. She completed her pediatric residency at Robert Wood Johnson University Hospital and pediatric critical care fellowship at Duke University, receiving funding under a Ruth L. Kirschstein National Research Service Award T-32 multi-disciplinary pediatric research training grant.

She divides her clinical time between the Pediatric Intensive Care Unit and the Critical Care Extracorporeal Membrane Oxygenation Service.  She enjoys participating in the education of medical students, residents and fellows.  She leads the ICU liberation team in the PICU, partnering with nursing, therapists and other ancillary staff to enhance the prevention of delirium and post-intensive care syndrome amongst the patients in the PICU.  She also acts as Medical Director to the Nemours Kids Transport Team, serving as a medical expert, advising policy change, designing the educational curriculum and approving medical equipment/personnel changes.

Since completing fellowship, she has served as site Principal Investigator on several NIH funded studies under the Pediatric Trials Network focusing on pharmacokinetics and pharmacodynamics of understudied drugs administered to children (POP01, AED01, ANA01, POP02). She is also site PI of the ARDS in Children and ECMO initiation strategies impact on Neuro-Development (ASCEND) trial. And most recently, she joined as co-investigator on a Multi-Center Observational Study: The RECOVER Post Acute Sequelae of SARS-C0V-2 (PASC) Pediatric Cohort Study.